MEDx (Suzhou) Translational Medicine Co., Ltd

MEDx (Suzhou) Translational Medicine Co., Ltd

Jiangsu,China

MEDx (Suzhou) Translational Medicine Co., Ltd

Jiangsu,China

favorite supplier

verified Copper Member
MEDx (Suzhou) Translational Medicine Co., Ltd
favorite supplier

MEDx (Suzhou) Translational Medicine Co., Ltd

Jiangsu,China

Scan QR code

Access to mobile station

Clear All
Alternate Text

HEMECDx Panel Kit (NGS)

FOB Price : Get a Price/Quote

Min.Order : 1 Piece(s)

Certification : OTHER

Brand Name : MEDx

Payment Terms : T/T

share :

product information

  • brand name : MEDx

  • certification : OTHER

  • min.order : 1 Piece(s)

  • warranty : 1 Year

  • payment terms : T/T

  • Packaging : /

  • Specification : 85*75*75mm

  • place of origin : China

product description

This product is a large Panel product (HEMECDx Panel) for hematologic tumor genetic testing based on the next-generation sequencing (NGS) platform to detect genetic variants of 505 genes, including single nucleotide variant (SNV), insertion/deletion (InDel) and fusions of 75 genes, providing clinical guidance for patients with hematological tumors on gene mutations, fusions, HLA typing, mismatch repair (MMR), microsatellite instability (MSI), tumor mutation burden (TMB) and tumor neoantigens, thus assisting clinical hematologic tumor diagnosis, prognosis assessment and medication guidance to achieve individualized medicine.

People who viewed this also viewed

  • HEMECDx Panel Kit (NGS)

    FOB Price :

    Min.Order : 1 Piece(s)

  • Microsatellite Instability (MSI) Dx Analysis Test

    FOB Price :

    Min.Order : 1 Piece(s)

  • c-MET Exon 14 Skipping RT-qPCR Test

    FOB Price :

    Min.Order : 1 Piece(s)

  • Claudin 18.2 Antibody Kit(IHC)

    FOB Price :

    Min.Order : 1 Piece(s)

  • MMR IHC Panel

    FOB Price :

    Min.Order : 1 Piece(s)

HEMECDx Panel Kit (NGS)
share :

product information

product description

This product is a large Panel product (HEMECDx Panel) for hematologic tumor genetic testing based on the next-generation sequencing (NGS) platform to detect genetic variants of 505 genes, including single nucleotide variant (SNV), insertion/deletion (InDel) and fusions of 75 genes, providing clinical guidance for patients with hematological tumors on gene mutations, fusions, HLA typing, mismatch repair (MMR), microsatellite instability (MSI), tumor mutation burden (TMB) and tumor neoantigens, thus assisting clinical hematologic tumor diagnosis, prognosis assessment and medication guidance to achieve individualized medicine.

Recommend

Join Free

Create New Account

Leave your contact information for the suppliers. If you're our member, Please Sign In to use your account information.

Sign in